Monitor the 2026 annual meeting proxy vote on the reverse stock split—approval is critical for regaining compliance. The stock may face selling pressure leading up to the November 4 deadline if no progress is made. Any trading halt or delisting update would be a material event.
Price Chart
Executive Summary
Rockwell Medical received a Nasdaq delisting notice on May 8, 2026 for failing to meet the $1.00 minimum bid price requirement over 30 consecutive business days. The company has until November 4, 2026 to regain compliance, and is seeking stockholder approval for a reverse stock split at its upcoming annual meeting. The filing signals near-term delisting risk, which could severely impact liquidity and institutional ownership.
Key Facts
- Nasdaq notified Rockwell Medical on May 8, 2026 of non-compliance with minimum bid price rule (closing bid below $1.00 for 30 consecutive business days)
- Company has 180 calendar days, until November 4, 2026, to regain compliance by closing at $1.00+ for 10 consecutive business days
- Rockwell Medical has included a reverse stock split proposal in its 2026 Annual Meeting proxy statement to potentially cure the deficiency
- No assurance that compliance will be achieved or that Nasdaq will grant additional time if needed
Financial Impact
Delisting risk; no direct financial figures provided in filing
Risk Factors
- Failure to regain compliance by November 4, 2026 could lead to delisting from Nasdaq Capital Market
- Reverse stock split may not be approved by stockholders or may not be sufficient to boost bid price
- Delisting would severely reduce liquidity and likely trigger further price declines
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-032987 |
| Document: 0001628280-26-032987-index.html | 0001628280-26-032987 |
| Document: 0001628280-26-032987.txt | 0001628280-26-032987 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 10w ago | 8-K | $7.83 | awaiting T+60 | — | $6.95 (−11.18%) |
Jul 20, 2026 14w ago | 8-K | $6.30 $7.85 | ▲ +24.70% | ▲ +19.86% | $6.95 (+10.41%) |
Jun 29, 2026 17w ago | 8-K | $0.5874 $0.8570 | ▲ +45.90% | ▲ +42.28% | $6.95 (+1083.18%) |
May 8, 2026 24w ago | 8-K | $8.40 $7.26 | ▲ +13.57% | ▲ +17.96% | $6.95 (+17.26%) |
May 7, 2026 24w ago | 8-K | $7.80 $7.23 | ▼ −7.31% | ▼ −11.14% | $6.95 (−10.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers